Your browser doesn't support javascript.
International consensus on lung function testing during the COVID-19 pandemic and beyond.
McGowan, Aisling; Laveneziana, Pierantonio; Bayat, Sam; Beydon, Nicole; Boros, P W; Burgos, Felip; Flezar, Matjaz; Franczuk, Monika; Galarza, Maria-Alejandra; Kendrick, Adrian H; Lombardi, Enrico; Makonga-Braaksma, Jellien; McCormack, Meredith C; Plantier, Laurent; Stanojevic, Sanja; Steenbruggen, Irene; Thompson, Bruce; Coates, Allan L; Wanger, Jack; Cockcroft, Donald W; Culver, Bruce; Sylvester, Karl; De Jongh, Frans.
  • McGowan A; Dept of Respiratory and Sleep Diagnostics, Connolly Hospital, Dublin, Ireland.
  • Laveneziana P; School of Physics, Clinical and Optometric Sciences, Technological University Dublin, Dublin, Ireland.
  • Bayat S; Sorbonne Université, INSERM, UMRS1158 Neurophysiologie Respiratoire Expérimentale et Clinique, Paris, France.
  • Beydon N; AP-HP, Groupe Hospitalier Universitaire APHP-Sorbonne Université, Service des Explorations Fonctionnelles de la Respiration, de l'Exercice et de la Dyspnée (Département R3S), Paris, France.
  • Boros PW; Centre Hospitalier Universitaire de Grenoble Alpes, Unité d'Explorations Fonctionnelles, Cardiorespiratoires, Grenoble, France.
  • Burgos F; Université Grenoble Alpes - INSERM UA7, Rayonnement Synchrotron pour la Recherche Biomédicale (STROBE), Grenoble, France.
  • Flezar M; Unité Fonctionnelle de Physiologie-Explorations Fonctionnelles Respiratoires, AP-HP Sorbonne Université, Hôpital Armand-Trousseau, Paris, France.
  • Franczuk M; Lung Pathophysiology Dept, National Tuberculosis and Lung Diseases Research Institute, Warsaw, Poland.
  • Galarza MA; Department of Pulmonary Medicine, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi I Sunyer, Universitat de Barcelona, CIBERES, Barcelona, Spain.
  • Kendrick AH; University Clinic of Respiratory and Allergic Diseases, Golnik, Slovenia.
  • Lombardi E; Medical Faculty, University of Ljubljana, Ljubljana, Slovenia.
  • Makonga-Braaksma J; Lung Pathophysiology Dept, National Tuberculosis and Lung Diseases Research Institute, Warsaw, Poland.
  • McCormack MC; Sorbonne Université, INSERM, UMRS1158 Neurophysiologie Respiratoire Expérimentale et Clinique, Paris, France.
  • Plantier L; AP-HP, Groupe Hospitalier Universitaire APHP-Sorbonne Université, Service des Explorations Fonctionnelles de la Respiration, de l'Exercice et de la Dyspnée (Département R3S), Paris, France.
  • Stanojevic S; Dept of Respiratory Medicine, University Hospitals Bristol & Weston NHS Trust, Bristol, UK.
  • Steenbruggen I; University of West of England, Bristol, UK.
  • Thompson B; School of Physiology, Pharmacology and Neurophysiology, University of Bristol, Bristol, UK.
  • Coates AL; Pediatric Pulmonary Unit, Anna Meyer Pediatric University Hospital, Florence, Italy.
  • Wanger J; Lung Function Dept, Meander Medisch Centrum, Amersfoort, The Netherlands.
  • Cockcroft DW; Pulmonary Function Laboratory, Pulmonary and Critical Care Medicine, Johns Hopkins University, Baltimore, MD, USA.
  • Culver B; Pulmonology and Lung Function Testing, CHRU de Tours, Tours, France.
  • Sylvester K; University of Tours, CEPR/Inserm UMR1100, Tours, France.
  • De Jongh F; Dept of Community Health and Epidemiology, Dalhousie University, New Brunswick, NS, Canada.
ERJ Open Res ; 8(1)2022 Jan.
Article in English | MEDLINE | ID: covidwho-1533243
ABSTRACT
Coronavirus disease 2019 (COVID-19) has negatively affected the delivery of respiratory diagnostic services across the world due to the potential risk of disease transmission during lung function testing. Community prevalence, reoccurrence of COVID-19 surges and the emergence of different variants of SARS-CoV-2 have impeded attempts to restore services. Finding consensus on how to deliver safe lung function services for both patients attending and for staff performing the tests are of paramount importance. This international statement presents the consensus opinion of 23 experts in the field of lung function and respiratory physiology balanced with evidence from the reviewed literature. It describes a robust roadmap for restoration and continuity of lung function testing services during the COVID-19 pandemic and beyond. Important strategies presented in this consensus statement relate to the patient journey when attending for lung function tests. We discuss appointment preparation, operational and environmental issues, testing room requirements including mitigation strategies for transmission risk, requirement for improved ventilation, maintaining physical distance and use of personal protection equipment. We also provide consensus opinion on precautions relating to specific tests, filters, management of special patient groups and alternative options to testing in hospitals. The pandemic has highlighted how vulnerable lung function services are and forces us to re-think how long-term mitigation strategies can protect our services during this and any possible future pandemic. This statement aspires to address the safety concerns that exist and provide strategies to make lung function tests and the testing environment safer when tests are required.

Full text: Available Collection: International databases Database: MEDLINE Type of study: Diagnostic study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Variants Language: English Year: 2022 Document Type: Article Affiliation country: 23120541.00602-2021

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Diagnostic study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Variants Language: English Year: 2022 Document Type: Article Affiliation country: 23120541.00602-2021